Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Country/Region as subject
Language
Publication year range
1.
Am J Physiol Heart Circ Physiol ; 297(4): H1494-503, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19700624

ABSTRACT

A role for nitric oxide (NO) produced during the reduction of nitrite by deoxygenated red blood cells (RBCs) in regulating vascular dilation has been proposed. It has not, however, been satisfactorily explained how this NO is released from the RBC without first reacting with the large pools of oxyhemoglobin and deoxyhemoglobin in the cell. In this study, we have delineated a mechanism for nitrite-induced RBC vasodilation that does not require that NO be released from the cell. Instead, we show that nitrite enhances the ATP release from RBCs, which is known to produce vasodilation by several different methods including the interaction with purinergic receptors on the endothelium that stimulate the synthesis of NO by endothelial NO synthase. This mechanism was established in vivo by measuring the decrease in blood pressure when injecting nitrite-reacted RBCs into rats. The observed decrease in blood pressure was not observed if endothelial NO synthase was inhibited by N(omega)-nitro-L-arginine methyl ester (L-NAME) or when any released ATP was degraded by apyrase. The nitrite-enhanced ATP release was shown to involve an increased binding of nitrite-modified hemoglobin to the RBC membrane that displaces glycolytic enzymes from the membrane, resulting in the formation of a pool of ATP that is released from the RBC. These results thus provide a new mechanism to explain nitrite-induced vasodilation.


Subject(s)
Adenosine Triphosphate/blood , Erythrocytes/metabolism , Nitric Oxide/blood , Nitrites/blood , Vasodilation , Adenosine Triphosphate/administration & dosage , Animals , Apyrase/pharmacology , Blood Pressure , Cell Hypoxia , Enzyme Inhibitors/pharmacology , Erythrocyte Membrane/metabolism , Erythrocytes/drug effects , Erythrocytes/enzymology , Hemoglobins/metabolism , Hydrolysis , Injections, Intravenous , Male , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type III/blood , Nitrites/administration & dosage , Rats , Rats, Wistar , Time Factors , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL